Phase I – Other

1,081 trials 241 recruiting

Filter these 1,081 trials by condition, country, sponsor and more.

Open in Search →

A study of Mirdametinib in Infants and Toddlers under 24months of age with Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas… Pending

2025-522000-24-00 Neurofibromatosis Type 1 (NF1) Associated Plexiform Neu
Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma… Pending

2025-524031-39-00 Medulloblastoma (recurrent or progressive)
A study to learn more about the amount of bimekizumab in the breast milk of women with chronic inflammatory conditions who are breastfeeding Pending

2024-518689-29-00 Hidradenitis suppurativa
Three-part PK and PD study of AXN-027 Recruiting

2025-524019-35-00 Chronic pain, refractory epilepsy, and other neurologic 2026-06-29
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma Recruiting

2025-524953-15-00 Uveal melanoma 2026-06-29
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who ar… Recruiting

2026-525543-32-00 Recurrent glioblastoma 2026-06-17
A clinical trial to learn about the effects of DAK539 on the blood levels of repaglinide, midazolam, drospirenone, and ethinyl estradiol in … Recruiting

2025-521000-22-00 Patients with advanced malignancies 2026-06-12
A multiCenter phase I study of aUtologous CD19 CAR T cElls for therapy refractory chronic GvHD (CURE-cGvHD) Recruiting

2025-524468-40-00 chronic Graft-versus-Host-Disease (cGvHD) 2026-06-09
An Early-Stage Study in Multiple Clinics of how Afimkibart May Affect the Body’s Processing of Medicines that Rely on Cytochrome P450 Enzyme… Recruiting

2025-524060-38-00 Active Ulcerative Colitis (UC) 2026-05-28
Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial Recruiting

2025-522128-28-00 Breast cancer 2026-05-26
150 mg CIT-013 phase 1 trial Recruiting

2026-526153-34-00 Immune mediated inflammatory diseases 2026-05-26
Phase 1 trial of valemetostat and darolutamide in mCRPC Recruiting

2025-522512-16-00 Metastatic Castration Resistant Prostate Cancer (mCRPC) 2026-04-23
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting

2025-522125-36-00 Chronic hepatitis D infection 2026-04-22
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab. Recruiting

2025-521639-34-00 • Non-small cell lung cancer (Stage III, unresectable) 2026-04-20
A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults Recruiting

2025-522782-30-00 CCI 2026-04-07
A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product Recruiting

2024-520222-11-00 Hematological or solid tumor malignancies or autoimmune 2026-03-03
A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms. Recruiting

2024-520353-21-00 Myeloproliferative Neoplasms 2026-02-24
A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid art… Recruiting

2025-522273-10-00 Rheumatoid Arthritis 2026-02-24
A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III me… Recruiting

2025-521919-39-00 Resected stage IIB, IIC, or III melanoma requiring adju 2026-02-10
Personalized Treatment for Endometriosis: A Study on the Safety and Kinetics of Dienogest in Women with Different Gene Variants Recruiting

2025-521026-15-00 Healthy volunteers 2025-12-11
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment Recruiting

2024-517923-38-00 Newly diagnosed and/or previously treated IDH1-mutated 2025-12-10
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Partic… Recruiting

2024-519157-10-00 Systemic Lupus Erythematosus 2025-11-24
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a… Recruiting

2024-520196-27-00 Rheumatoid Arthritis 2025-10-01
Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma Recruiting

2024-516233-12-00 Advanced pancreatic adenocarcinoma 2025-08-08